SUMMARY A prospective study 
with HMFG2 and B72.3 monoclonal antibodies) permitted diagnosis on the effusions of most cases of mesothelioma.
The impact of the diagnosis on the progress of the disease was not appreciable as no difference in outcome was noted, irrespective of whether cancer cells had been recognised. The occurrence of an effusion remains an ominous sign in most patients treated for cancer.
The diagnosis of pleural, peritoneal and pericardial effusions remains one of the most difficult tasks in diagnostic cytology,' yet it is of paramount importance for determining the nature, either reactive or neoplastic, of the underlying disease.
The diagnosis is made on smears or embedded sediments and is based on classical morphological criteria, the most difficult problem being the differentiation of neoplastic cells from reactive mesothelial cells. 2 
Material and methods
The effusion samples arriving at the cytology laboratory of this department were all routinely processed by centrifugation, followed by smearing and treatment of the sediment by fixation in 95% ethanol and paraffin wax embedding using the "cell bag" procedure"' in common use in this laboratory for the past seven years. Smears were stained by the Papanicolaou method, and paraffin wax sections were stained by haematoxylin and eosin and, in selected cases, with periodic acid Schiff (PAS) with or without diastase treatment.
Immunoperoxidase staining was performed on paraffin wax sections of the embedded sediment. 1184 Impact ofimmunocytochemistry in cytological diagnosis ofneoplastic effusions Endogenous peroxidase was blocked by hydrogen peroxide-periodic acid-sodium periodate treatment.'8 After a short treatment with non-immune serum the sections were treated overnight at room temperature with HMFG2 (kindly supplied, as culture supernatant, by Dr Taylor-Papadimitriou, ICRF, London) at a 1/200 dilution. The characteristics of this monoclonal antibody were originally reported by Arklie et al."9 Biotinylated anti-mouse immunoglobulin antiserum (from horse) and avidin-biotin peroxidase complexes' were then used according to the ABC procedure. The colour reaction was developed with H202-DAB. Nuclei were counterstained with haemalum. Sections of breast, lung, and colorectal adenocarcinomas were used as positive controls. Additional controls were cytologically positive effusion sediments from carcinomas of the breast (10 cases) and cytologically negative cases from patients with clinically confirmed non-neoplastic diseases (cyrrhosis, four cases; heart failure, three cases; pleuritis, two cases; peritonitis, one case). The former were HMFG2 positive, while reactive mesothelial cells were negative.
From 1984 to 1987 inclusive a total of 2362 serous effusions from pleural (n = 1314), peritoneal (n = 1009), and pericardial (n = 39) cavities were examined in this laboratory. In 540 (23%) cases a positive diagnosis for neoplastic cells was made, while in 1515 (64%) cases the diagnosis was negative.
In 352 (15%) specimens from 307 patients, no definite diagnosis was reached on morphological criteria alone, and diagnosis was deferred pending immunocytochemical staining. Sections of the embedded sediment were tested with HMFG2. Where mesothelioma was suspected, additional sections were stained with monoclonal antibodies anti-CEA and B72.3 (both from Sorin, Saluggia, at a dilution of 1/30 and 1/4, respectively). In both cases the ABC immunoperoxidase procedure was used. The characteristics ofmonoclonal B72.3, which detects a carcinomaassociated antigen, have been reported by Nuti et al. 9 The clinical diagnosis was confirmed in all patients. In some of the cases cytological examination of the effusion sample had been requested as confirmatory in cancer patients, while in other cases with unknown underlying disease its role was diagnostic and therefore more critical. Of the 307 patients, follow up was possible for only 296, over a minimum of 12 months and a maximum of 48 months (mean 18 months). In these patients we took into consideration both the clinical diagnosis at discharge from the hospital and the outcome of the disease.
To estimate the predictive value, specificity, and sensitivity of the HMFG2 test for recognising the nature of the disease (either neoplastic or reactive), we only considered cases with complete follow up and with certain diagnosis. Cases affected by nonepithelial neoplasias, doubtful immunocytochemical results and patients dead of a disease clinically regarded as non-neoplastic, but which had not undergone necropsy, were excluded.
The sensitivity, specificity, and predictive value of a positive test were calculated according to the method of Galen and Gambino.2'
Results
The 352 cases with uncertain cytological diagnosis (15% of the total) were investigated by immunoperoxidase staining with HMFG2, on sections from the embedded sediment parallel to those already stained by the routine procedure. These cases were mostly from patients suspected of having metastases (one third ofthe cases with breast cancer) but in 20% of the cases no definite clinical suspicion had been raised. In 34 patients the immunocytochemical test was repeated more than once at different times; in 20 cases (50 tests) the results were always positive, while in 14 (29 tests) they were always negative. No discrepancies were observed.
In The reasons for submitting the effusion to cytological diagnosis were different for the various pathological lesions: in many cases and specifically in all breast cancer patients, the request was confirmatory, as they had always been operated on at an earlier date and the effusion appeared as a later development of the disease; in other cases the request was diagnostic. The diagnosis was reached by cytology and immunocytochemistry alone in five cases of ovarian cancer, five cases of gastric or colon cancer, one case of kidney cancer, eight cases of lung cancer, 10 of mesothelioma and in 29 patients with inconclusive clinical diagnosis.
All patients with a final diagnosis ofcancer (cases of mesothelioma included) had the diagnosis confirmed by histology, performed before or (in the "diagnostic" cases) after the cytological examination.
Thirty patients died of apparently unrelated cardiovascular diseases (18 of cardiac infarction, two of pulmonary embolism, ten of heart failure).
The results of follow up (tables 1-4) indicate that most patients died of cancer shortly after diagnosis. Seventeen patients died of apparently unrelated disease; necropsy was not performed and presence or absence of tumour could not be ascertained. Only 52 patients are still alive and without evidence ofneoplastic disease at the time of writing. Thirty four of these had a histologically confirmed diagnosis of cancer; of these, 23 had a positive immunocytochemical diagnosis, three an inconclusive, and eight a negative result. All these patients underwent chemotherapy, hormone therapy, or radiotherapy because of the cytohistological, clinical and radiological evidence of metastases, and their present clinical state is probably related to the therapeutic regimen. No significant difference in the development of the neoplastic disease was therefore established between those cancer patients in whom a positive immunocytochemical diagnosis had been made and those with a negative or inconclusive immunocytochemical diagnosis. Eighteen immunocytochemically negative patients (table 4) were clinically diagnosed as being either free of cancer (11 cases) or doubtful (seven cases): they received no further treatment and are still alive with no evidence of tumour at the time of writing.
The predictive value of a positive HMFG2 test and the specificity were 100%; the sensitivity was only 41%.
Discussion
Cytopathological diagnosis of malignant pleural effusions is based on the experience of the examiner and the quality of the cytological technique. 6 The percentage of reported cytologically positive diagnoses varies from 10 to 49%67 and seems mainly related to patient selection. In cases observed by us between 1984 and 1987, 540 cases, representing 23% of a total of 2362 effusions examined, were diagnosed as positive for neoplastic cells on the basis of cytology alone.
Besides those cases diagnosed as frankly malignant and those reported as either inflammatory, or reactive, or as serous effusions (with mesothelial cells, lymphocytes and macrophages, or granulocytes as the only cellular components), we considered cases where cells with relatively large and rather hyperchromatic nuclei were encountered in variable numbers. These cells were isolated or occurred in small clusters and could best be defined as suspicious. 
